Skip Navigation LinksHome > September/October 2013 - Volume 5 - Issue 5 > Bimatoprost in the Treatment of Hypotrichosis
Journal of the Dermatology Nurses' Association:
doi: 10.1097/JDN.0b013e3182a52462
Feature Articles

Bimatoprost in the Treatment of Hypotrichosis

Bratton, Emily M.; Davies, Brett W.; Hink, Eric M.; Durairaj, Vikram D.

Collapse Box


Hypotrichosis plays a role in the perception of beauty and attractiveness for many patients. Bimatoprost ophthalmic solution (0.03%; Latisse, Allergan, Inc., Irvine, CA) aids in the treatment of hypotrichosis and offers a safe and effective method of achieving fuller, darker, and longer eyelashes, creating an aesthetically pleasing outcome. Nursing staff must obtain a comprehensive basis of knowledge with regard to the pharmacology, accurate application, and side effects of the drug in order to counsel patients on appropriate use and expected outcome.

Copyright © 2013 Dermatology Nurses’ Association


Search for Similar Articles
You may search for similar articles that contain these same keywords or you may modify the keyword list to augment your search.